4.7.1. Insomnia

Kent and Medway PRGC Policy recommendation on Melatonin for Jet Lag -  Click Here

Kent & Medway Guideline on the Use of Melatonin for the Management of Sleep Disorders in Children, Adolescents, and Adults -  Click Here

For Position Statement on the Off label use of Chloral Hydrate in the Management of Intrusive Movement and Motor Disorders in Children and Young People and summary for use in insomnia  & MHRA Drug Safety Update Click Here

For Controlled drugs/benzodiazepine prescribing patient treatment
agreement  Click Here

Daridorexant should be prescribed in line with this Kent and Medway guidance
Daridorexant Prescribing Guidance Click Here
NICE TA 922 : Daridorexant for treating long-term insomnia
Daridorexant is recommended for treating insomnia in adults with symptoms lasting for 3 nights or more per week for at least 3 months in line with the NHS Kent and Medway guidance. The length of treatment should be as short as possible. Treatment with Daridorexant should be assessed within 3 months of starting and should be stopped in people whose long-term insomnia has not responded adequately. If treatment is continued, assess whether it is still working at regular intervals. The initiating clinician is responsible for the 3 month assessment of efficacy.